• Hours: Monday-Friday 9am-5pm

  • 732-389-1530

C. difficile Toxin A/B Rapid Enzyme Immunoassay (EIA)2022-10-18T15:55:59+00:00

Laboratory of Choice

Children are not things to be molded but are people to be unfolded.

Science-first leaders whose compassion for healthcare providers and patients is incomparable.

Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Nulla porttitor accumsan tincidunt.

C. difficile Toxin A/B Rapid Enzyme Immunoassay (EIA)

C. difficile carrier state is common (about 10% of adults and a much higher incidence in infants and children). Detection of toxigenic C. difficile on PCR does not automatically imply that C. difficile infection (CDI) is causing a particular case of diarrhea, as many studies show that other pathogens may be responsible for acute diarrhea in many C. difficile carriers. To provide more information in such a scenario, our lab reflexes all samples detected to have C. difficile on FilmArray® testing to a further C. difficile Toxin A/B rapid enzyme immunoassay (EIA) test to help differentiate the presence of C. difficile infection (CDI) from a carrier state. Most clinical and laboratory experts agree that testing for stool Toxin A/B should be a part of making a diagnosis of CDI. However, it seems to be rarely performed in most commercial laboratories in such situations1.

Keep up-to-date with Genesis Labs.

Go to Top